GB9818004D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB9818004D0
GB9818004D0 GBGB9818004.5A GB9818004A GB9818004D0 GB 9818004 D0 GB9818004 D0 GB 9818004D0 GB 9818004 A GB9818004 A GB 9818004A GB 9818004 D0 GB9818004 D0 GB 9818004D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9818004.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
SmithKline Beecham Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Biologicals SA filed Critical SmithKline Beecham Biologicals SA
Priority to GBGB9818004.5A priority Critical patent/GB9818004D0/en
Publication of GB9818004D0 publication Critical patent/GB9818004D0/en
Priority to CA002341079A priority patent/CA2341079A1/en
Priority to EP99944404A priority patent/EP1105493A1/en
Priority to AU57352/99A priority patent/AU5735299A/en
Priority to PCT/EP1999/005989 priority patent/WO2000011182A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
GBGB9818004.5A 1998-08-18 1998-08-18 Novel compounds Ceased GB9818004D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB9818004.5A GB9818004D0 (en) 1998-08-18 1998-08-18 Novel compounds
CA002341079A CA2341079A1 (en) 1998-08-18 1999-08-13 Basb024 outer membrane protein of neisseria meningitidis
EP99944404A EP1105493A1 (en) 1998-08-18 1999-08-13 Basb024 outer membrane protein of neisseria meningitidis
AU57352/99A AU5735299A (en) 1998-08-18 1999-08-13 Basb024 outer membrane protein of neisseria meningitidis
PCT/EP1999/005989 WO2000011182A1 (en) 1998-08-18 1999-08-13 Basb024 outer membrane protein of neisseria meningitidis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9818004.5A GB9818004D0 (en) 1998-08-18 1998-08-18 Novel compounds

Publications (1)

Publication Number Publication Date
GB9818004D0 true GB9818004D0 (en) 1998-10-14

Family

ID=10837459

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9818004.5A Ceased GB9818004D0 (en) 1998-08-18 1998-08-18 Novel compounds

Country Status (5)

Country Link
EP (1) EP1105493A1 (en)
AU (1) AU5735299A (en)
CA (1) CA2341079A1 (en)
GB (1) GB9818004D0 (en)
WO (1) WO2000011182A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0103171D0 (en) 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition
CA2452836C (en) 2001-07-27 2012-11-27 Chiron Srl Meningococcus adhesins nada, app and orf 40
SI1524993T1 (en) * 2002-08-02 2013-07-31 Glaxosmithkline Biologicals S.A. Neisserial vaccine compositions comprising a combination of antigens
JP4697706B2 (en) 2002-10-11 2011-06-08 ノバルティス ヴァクシンズ アンド ダイアグノスティクス エスアールエル Polypeptide-vaccine for broad protection against highly virulent meningococcal strains
JP2013522177A (en) 2010-03-11 2013-06-13 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム Immunogenic compositions or vaccines against gram-negative bacterial, eg meningococcal infections or diseases
BR112014019166A2 (en) 2012-02-02 2017-07-04 Novartis Ag promoters for increased protein expression in meningococci

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU22559A1 (en) * 1996-01-17 1999-05-03 Ct Ingenieria Genetica Biotech EXPRESSION SYSTEM OF HETEROLOGICAL ANTIGENS IN E. COLI AS FUSION PROTEINS
WO1997028273A1 (en) * 1996-02-01 1997-08-07 North American Vaccine, Inc. Expression of group b neisseria meningitidis outer membrane (mb3) protein from yeast and vaccines
CN1263854C (en) * 1997-11-06 2006-07-12 启龙股份公司 Neisserial antigens

Also Published As

Publication number Publication date
EP1105493A1 (en) 2001-06-13
WO2000011182A1 (en) 2000-03-02
CA2341079A1 (en) 2000-03-02
AU5735299A (en) 2000-03-14

Similar Documents

Publication Publication Date Title
GB9801392D0 (en) Novel compounds
GB9808734D0 (en) Novel compounds
GB9818004D0 (en) Novel compounds
GB9802801D0 (en) Novel compounds
GB9801882D0 (en) Novel compounds
GB9802653D0 (en) Novel compounds
GB9802645D0 (en) Novel compounds
GB9802644D0 (en) Novel compounds
GB9814290D0 (en) Novel compounds
GB9802640D0 (en) Novel compounds
GB9802639D0 (en) Novel compounds
GB9802638D0 (en) Novel compounds
GB9803306D0 (en) Novel compounds
GB9803290D0 (en) Novel compounds
GB9802533D0 (en) Novel compounds
GB9802387D0 (en) Novel compounds
GB9802807D0 (en) Novel compounds
GB9801643D0 (en) Novel compounds
GB9801635D0 (en) Novel compounds
GB9801634D0 (en) Novel compounds
GB9801633D0 (en) Novel compounds
GB9801632D0 (en) Novel compounds
GB9801630D0 (en) Novel compounds
GB9800337D0 (en) Novel compounds
GB9800324D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)